Library
Repeated intravenous esketamine treatment in patients with ECT-resistant major depressive disorder
22 August 2022.
A.Safai Pour, S.J.M.van der Aalst, I.J.Brouwer, E.J.Giltay, G.E.Jacobs, N.J.A.van der Wee, A.M.van Hemert, M.S.van Noorden
View publicationhttps://www.sciencedirect.com/science/article/pii/S2666915322000920?via%3Dihub
Advancing the boundaries of clinical drug development
Wondering how we can help you? Reach out to us.
